A pathway-based classification of human breast cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2010-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0912708107PMID 20335537PMCID PMC2872436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

  2009cited by this paper
• Statistical Applications in Genetics and Molecular Biology

  2009cited by this paper
• An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer

  2009cited by this paper
• A genomic strategy to elucidate modules of oncogenic pathway signaling networks.

  2009cited by this paper
• Subtypes of breast cancer show preferential site of relapse.

  2008cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.

  2008cited by this paper
• Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

  2008cited by this paper
• High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics

  2008cited by this paper
• Comparison of gene expression data from human and mouse breast cancers: Identification of a conserved breast tumor gene set

  2007cited by this paper
• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis

  2007cited by this paper
• Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.

  2007cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006influential reference
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006influential reference
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

  2006cited by this paper
• X chromosomal abnormalities in basal-like human breast cancer.

  2006cited by this paper
• Erlotinib in lung cancer - molecular and clinical predictors of outcome.

  2005cited by this paper
• Identification of molecular apocrine breast tumours by microarray analysis

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

  2005cited by this paper
• Erlotinib in previously treated non-small-cell lung cancer.

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• Circular binary segmentation for the analysis of array-based DNA copy number data.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Gene expression phenotypic models that predict the activity of oncogenic pathways

  2003influential reference
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000influential reference
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper

• Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value

  2026cites this paper
• Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer

  2025cites this paper
• MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer

  2025cites this paper
• Signaling pathway dysregulation in breast cancer

  2025cites this paper
• Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial

  2025cites this paper
• MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian Cancer

  2024cites this paper
• Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features

  2024cites this paper
• Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers

  2024cites this paper
• Transformer-based deep learning integrates multi-omic data with cancer pathways

  2024cites this paper
• Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer

  2024cites this paper
• Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics

  2024cites this paper
• Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model

  2024cites this paper
• DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways

  2024cites this paper
• Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer

  2023cites this paper
• Phenotypic subtyping via contrastive learning

  2023cites this paper
• Gene-Expression Profiling to Decipher Breast Cancer Inter- and Intratumor Heterogeneity.

  2023cites this paper
• Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer

  2023cites this paper
• Automated Extraction of Molecular Interactions and Pathway Knowledge using Large Language Model, Galactica: Opportunities and Challenges

  2023cites this paper
• RE: [HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1].

  2023cites this paper
• HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling.

  2023cites this paper
• Comparative Performance Evaluation of Large Language Models for Extracting Molecular Interactions and Pathway Knowledge

  2023cites this paper
• Thinking (Metastasis) outside the (Primary Tumor) Box

  2023cites this paper
• The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

  2023cites this paper
• Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classification

  2023cites this paper
• Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors

  2023cites this paper
• CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer

  2023cites this paper
• Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

  2023cites this paper
• Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

  2023cites this paper
• Exploring the Efficacy of Targeted Therapies in Breast Cancer: A Comprehensive Review

  2023cites this paper
• Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective

  2023cites this paper
• Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors

  2023cites this paper
• CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

  2022cites this paper
• Axin1 Protects Colon Carcinogenesis by an Immune-Mediated Effect

  2022cites this paper
• Comprehensive analysis of gene expression profiles to radiation exposure reveals molecular signatures of low-dose radiation response

  2022cites this paper
• Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

  2022cites this paper
• The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets

  2022cites this paper
• Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses’ health study

  2022cites this paper
• Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer

  2022cites this paper
• Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping

  2022cites this paper
• CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression

  2022cites this paper
• Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

  2022cites this paper
• RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.

  2022cites this paper
• CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response

  2022cites this paper
• Identifying Associations between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center Radiogenomic Study

  2022cites this paper
• MYC and therapy resistance in cancer: risks and opportunities

  2022cites this paper
• Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers

  2021cites this paper
• An Ensemble Classification Method for High-Dimensional Data Using Neighborhood Rough Set

  2021cites this paper
• Insight into mammary gland development and tumor prevention in a newly developed metastatic mouse model of breast cancer

  2021cites this paper
• Exploring Pathway-Based Group Lasso for Cancer Survival Analysis: A Special Case of Multi-Task Learning

  2021cites this paper
• A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors

  2021cites this paper
• RETRACTED ARTICLE: Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung

  2021cites this paper
• Translational bioinformatics methods for drug discovery and drug repurposing

  2021cites this paper
• Progression to Metastasis of Solid Cancer

  2021cites this paper
• SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2

  2021cites this paper
• On the Use of Topological Features of Metabolic Networks for the Classification of Cancer Samples

  2021cites this paper
• Luminal A breast cancer resistance mechanisms and emerging treatments

  2021cites this paper
• Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status

  2021cites this paper
• TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers

  2021cites this paper
• Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis

  2021cites this paper
• Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer

  2021cites this paper
• Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies.

  2021cites this paper
• The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype

  2020cites this paper
• AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer

  2020cites this paper
• Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids

  2020cites this paper
• Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression

  2020cites this paper
• MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers

  2020cites this paper
• A metastasis map of human cancer cell lines

  2020cites this paper
• BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.

  2020cites this paper
• A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients

  2020cites this paper
• A Genotype-Based Ensemble Classifier System for Non-Small-Cell Lung Cancer

  2020cites this paper
• Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer

  2020cites this paper
• Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers

  2020cites this paper
• scTPA: A web tool for single-cell transcriptome analysis of pathway activation signatures

  2020cites this paper
• AKT1 mediates multiple phosphorylation events that functionally promote HSF1 activation

  2020cites this paper
• The requirement for cyclin E in c-Myc overexpressing breast cancers

  2020cites this paper
• Cancer subtype classification and modeling by pathway attention and propagation

  2020cites this paper
• Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors

  2019cites this paper
• An Anaplastic Lymphoma Kinase Pathway Signature is associated with Cell De-differentiation, Neoadjuvant Response and Recurrence Risk in Breast Cancer

  2019cites this paper
• Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance

  2019cites this paper
• Applications of Microarray in Cancer Cell Signaling Pathways

  2019cites this paper
• Low E2F2 activity is associated with high genomic instability and PARPi resistance

  2019cites this paper
• Molecular stratification within triple-negative breast cancer subtypes

  2019cites this paper
• PI3K–AKT Signaling Activation and Icariin: The Potential Effects on the Perimenopausal Depression-Like Rat Model

  2019cites this paper
• Screening of core genes and pathways in breast cancer development via comprehensive analysis of multi gene expression datasets

  2019cites this paper
• Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells

  2019cites this paper
• A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

  2019cites this paper
• Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

  2019cites this paper
• Whole genome sequencing of breast cancer

  2019cites this paper
• A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling

  2019cites this paper
• Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.

  2019cites this paper
• Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis

  2019cites this paper
• E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration

  2019cites this paper
• Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer

  2019cites this paper
• Integrated analyses of murine breast cancer models reveal critical parallels with human disease

  2019cites this paper
• Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip

  2019cites this paper
• Applications of Computational Systems Biology in Cancer Signaling Pathways

  2019cites this paper
• Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma

  2019cites this paper
• Histomorphological and molecular profiling: friends not foes! Morpho‐molecular analysis reveals agreement between histological and molecular profiling

  2019cites this paper
• PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

  2019cites this paper
• Une isoforme de Allograft Inflammatory Factor-1 (AIF1) impliquée dans le cancer du sein

  2018cites this paper